TREATMENT AND OUTCOME IN EARLY-ONSET BIPOLAR DISORDER

早发性双相情感障碍的治疗和结果

• 批准号: 7377115
• 负责人: VIVIAN KAFANTARIS
• 金额: $ 35.28万
• 依托单位: FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-04-01 至 2007-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7377115
• 关键词: TREATMENT; OUTCOME; EARLY; ONSET; BIPOLAR

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The long term goal of this project is to develop treatment regiments to minimize the morbidity associated with early-onset bipolar disorder. Once specific aim of the proposed study is to critically assess the efficacy of adjunctive antipsychotic medication during maintenance treatment of mania with psychotic feature or severe aggression in adolescents. The second specific aim is to describe the short-term course, neurocognitive functioning and functional outcomes of patients in our sample.

该子项目是利用 NIH/NCRR 资助的中心拨款提供的资源的众多研究子项目之一。子项目和研究者 (PI) 可能已从另一个 NIH 来源获得主要资金，因此可以在其他 CRISP 条目中出现。列出的机构是中心的机构，不一定是研究者的机构。该项目的长期目标是开发治疗方案，以尽量减少与早发性双相情感障碍相关的发病率。拟议研究的具体目的是严格评估辅助抗精神病药物在青少年具有精神病特征或严重攻击行为的躁狂症维持治疗期间的疗效。第二个具体目标是描述我们样本中患者的短期病程、神经认知功能和功能结果。